Package Leaflet: Information for the User
MST CONTINUS 100 mg prolonged-release tablets
Morphine sulfate
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack and other information:
These tablets have been prescribed for you by your doctor to relieve severe pain over a period of 12 hours. They contain the active substance morphine, which belongs to a group of medicines called strong painkillers.
Do not take this medicine
Tolerance, dependence, and addiction
This medicine contains morphine, which is an opioid. Repeated use of opioids can lead to reduced effectiveness of the medicine (getting used to it, also known as tolerance). Repeated use of this medicine can also lead to dependence, abuse, and addiction, which could result in a potentially fatal overdose. The risk of these side effects may be greater with higher doses and longer use.
Dependence or addiction can cause a feeling of lack of control over the amount of medicine you need to use or how often you need to use it.
The risk of dependence or addiction varies from person to person. You may have a greater risk of dependence or addiction to this medicine if:
If you notice any of the following symptoms while taking this medicine, it could be a sign of dependence or addiction:
If you notice any of these symptoms, consult your doctor to determine the best course of treatment for you, including when it is appropriate to stop the medicine and how to do so safely (see section 3 "If you stop treatment with MST CONTINUS").
If you are going to have an operation, please tell your doctor that you are taking these tablets.
Warnings and precautions
Consult your doctor or pharmacist before starting to take this medicine.
Before starting treatment with these tablets, tell your doctor or pharmacist if you:
It has been reported that acute generalized exanthematous pustulosis (AGEP) is associated with the use of this medicine. Symptoms usually occur within the first 10 days of treatment. Tell your doctor if you have ever suffered from a severe skin rash or skin peeling, blisters, and/or sores in the mouth after taking morphine or other opioids. Stop using this medicine and seek immediate medical attention if you notice any of the following symptoms: blisters, widespread skin peeling, or pus-filled bumps (pustules) along with fever.
Sleep-related breathing disorders
This medicine may cause sleep-related breathing problems such as sleep apnea (pauses in breathing during sleep) and sleep-related hypoxemia (low oxygen levels in the blood), or worsen existing breathing problems. Symptoms may include pauses in breathing during sleep, waking up at night due to shortness of breath, difficulty staying asleep, or excessive sleepiness during the day. If you or someone else notices these symptoms, contact your doctor. Your doctor may consider reducing the dose.
Tell your doctor or pharmacist if you experience any of the following symptoms while taking this medicine:
Contact your doctor if you experience severe abdominal pain that may radiate to your back, nausea, vomiting, or fever, as it could be symptoms associated with pancreatitis and bile duct problems.
This medicine should be used with caution when taking central nervous system depressant medicines (see "Taking MST CONTINUS with other medicines").
You may experience increased sensitivity to pain due to taking increasing doses of these tablets (hyperalgesia). Your doctor will decide if you need a change in your dose or switch to another strong painkiller.
Use in athletes
This medicine contains morphine, which may produce a positive result in doping tests.
Other medicines and morphine
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
It is particularly important that you tell your doctor if you are taking:
Also, tell your doctor if you have recently been treated with an anesthetic.
Do not take this medicine at the same time if you are taking a type of medicine for depression called monoamine oxidase inhibitors (MAOIs) or within two weeks after stopping the use of these medicines (see section 2 "Do not take...").
The concomitant use of morphine and sedative medicines such as benzodiazepines or related medicines increases the risk of drowsiness, breathing difficulties (respiratory depression), coma, and can put your life at risk. Due to this, concomitant use should only be considered when other treatment options are not possible.
However, if your doctor prescribes morphine along with sedative medicines, your doctor must limit the dose and duration of concomitant treatment.
Tell your doctor about all sedative medicines you are taking and follow the recommended dose carefully as advised by your doctor.
It may be helpful to inform friends or family members who are aware of the signs and symptoms mentioned above. Contact your doctor when you experience such symptoms.
Taking this medicine with food and alcohol
Drinking alcohol while taking this medicine can make you feel more drowsy or increase the risk of serious side effects such as shallow breathing with the risk of stopping breathing, and loss of consciousness. It is recommended not to drink alcohol while taking this medicine.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
The tablets of this medicine should be avoided as much as possible in patients who are pregnant or breastfeeding.
If this medicine is used for a prolonged period during pregnancy, there is a risk that the newborn may experience withdrawal symptoms that need to be treated by a doctor.
Driving and using machines
These tablets can cause a number of side effects such as drowsiness, which could affect your ability to drive or use machinery (see section 4 for a complete list of side effects). These effects are more noticeable when you start treatment with the tablets or when your dose is increased. If you are affected, do not drive or use machines.
Follow the instructions for administration of this medicine exactly as indicated by your doctor. If you are unsure, consult your doctor or pharmacist again.
Before starting treatment and periodically while treatment continues, your doctor will explain what you can expect from the use of this medicine, when and how long you need to take it, when to contact your doctor, and when to stop it (see also the section "If you stop treatment with MST CONTINUS").
The tablets should be swallowed whole and not chewed with a glass of water.
Do not chew, crush, or dissolve them.
The tablets of this medicine are designed to work properly for 12 hours when swallowed whole. If the tablet is broken, crushed, dissolved, or chewed, the full 12-hour dose may be absorbed quickly by your body. This can be dangerous, causing serious problems such as overdose, which can be fatal.
You should always take the tablets by mouth. The tablets should never be crushed or injected, as this can lead to serious side effects with a fatal outcome.
Do not increase the dose indicated by your doctor. If you do, you risk taking too much opioid (see section 4. Possible side effects).
There is a risk of tolerance (needing more doses to relieve pain) and addiction with strong opioid painkillers.
If you think the effect of this medicine is too strong or too weak, tell your doctor or pharmacist.
You should take your tablets every 12 hours. Therefore, if you take a tablet at 8 am, you should take the next one at 8 pm.
Severe chronic pain:
Adults:
The usual initial dose is one 30 mg tablet every 12 hours.
This dose will depend on the intensity of your pain, your age, and your previous history with pain relief therapy. Your doctor will decide the number of tablets you should take.
Patients treated with other oral morphine preparations who switch to a treatment with morphine prolonged-release tablets should receive the same total daily dose of morphine, but divided into two doses (one in the morning and one in the evening).
Children:
In case of severe and chronic pain, an initial dose of 0.2 to 0.8 mg/kg every 12 hours is recommended.
Elderly patients (> 65 years): It is advisable to reduce the dose.
Postoperative pain:
Adults: It is not recommended to use it in the first 24 hours after surgery; afterwards and always at the doctor's discretion, the following dosing schedule is suggested:
20 mg tablets every 12 hours in patients weighing less than 70 kg.
30 mg tablets every 12 hours in patients weighing more than 70 kg.
Children: It is not recommended to use this medicine for the treatment of postoperative pain in children.
Elderly patients (> 65 years): It is advisable to reduce the dose.
If you take more MST CONTINUS than you should
Tell your doctor immediately or go to your hospital. When you need medical attention, make sure to bring this leaflet and the tablets you have with you to show your doctor.
The signs of overdose and morphine toxicity are: small or pinpoint pupils, difficulty breathing, aspiration pneumonia, and low blood pressure. In more severe cases, circulatory failure and eventually deep coma may occur.
People who have taken an overdose may experience a brain disorder (known as toxic leukoencephalopathy) and suffer from aspiration pneumonia or inhalation of foreign particles; symptoms may include shortness of breath, cough, and fever.
People who have taken an overdose may also experience breathing difficulties that can lead to loss of consciousness or even death.
If you have taken too many tablets, under no circumstances should you put yourself in a situation that requires you to be alert, such as driving a car.
In case of overdose or accidental ingestion, consult the Toxicology Information Service, phone 915 620 420, indicating the medicine and the amount taken.
If you forget to take MST CONTINUS
If you forget to take a dose within 4 hours of the scheduled time, take a tablet as soon as possible. Take your next tablet at the usual time. If the delay in taking the tablet is more than 4 hours, consult your doctor or pharmacist.
Do not take a double dose to make up for forgotten doses.
If you stop treatment with MST CONTINUS
Do not stop treatment with this medicine unless your doctor advises you to do so. If you want to stop treatment, ask your doctor how to gradually reduce the dose to avoid withdrawal symptoms. Withdrawal symptoms may include general pain, tremors, diarrhea, stomach pain, nausea, flu-like symptoms, palpitations, and dilated pupils. Psychological symptoms include a deep feeling of dissatisfaction, anxiety, and irritability.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
All medicines can cause allergic reactions, although serious allergic reactions are rarely reported. Inform your doctor immediately if you suffer from:
The most serious adverse effect, although rare, is when your breathing becomes slower or weaker than normal (respiratory depression, a typical risk of opioid overdose).
Like all strong painkillers, there is a risk of addiction or physical and psychological tolerance to these tablets.
Very Common Adverse Effects
(May affect more than 1 in 10 patients)
Common Adverse Effects
(May affect up to 1 in 10 patients)
Uncommon Adverse Effects
(May affect up to 1 in 100 patients)
Frequency Not Known
(Cannot be estimated from the available data)
Reporting of Adverse Effects:
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is an adverse effect that is not listed in this leaflet. You can also report it directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of sight and reach of children.
Do not use this medicine after the expiration date that appears on the blister pack and carton, after CAD. The expiration date is the last day of the month indicated.
Keep the container perfectly closed to protect it from light and moisture. Store in the original packaging. Do not store at a temperature above 25°C.
Medicines should not be thrown away through wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE Point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition of MST CONTINUS
The active ingredient is morphine sulfate.
Each tablet contains 100 mg of morphine sulfate.
The other components are:
Appearance of MST CONTINUS and Package Contents
Film-coated tablets, biconvex, gray in color, with one smooth face and the concentration "100" marked on the other face.
Cardboard boxes containing 60 tablets in PVC/PVDC-Al blisters.
Marketing Authorization Holder
Mundipharma Pharmaceuticals, S.L.
Bahía de Pollensa, 11
28042 Madrid
Spain
Phone: 913 821 870
Manufacturer
Mundipharma DC B.V.
Leusderend 16
3832 RC Leusden
Netherlands
Date of the Last Revision of this Leaflet:November 2024
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)
The average price of MST CONTINUS 100 mg PROLONGED-RELEASE TABLETS in October, 2025 is around 73.59 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.